RMD - ResMed Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
21.59B
Enterprise Value 3
22.72B
Trailing P/E
51.79
Forward P/E 1
33.37
PEG Ratio (5 yr expected) 1
1.96
Price/Sales (ttm)
8.00
Price/Book (mrq)
10.20
Enterprise Value/Revenue 3
8.42
Enterprise Value/EBITDA 6
27.67

Trading Information

Stock Price History

Beta (3Y Monthly) 0.41
52-Week Change 336.51%
S&P500 52-Week Change 318.22%
52 Week High 3151.46
52 Week Low 390.64
50-Day Moving Average 3143.28
200-Day Moving Average 3131.16

Share Statistics

Avg Vol (3 month) 3529.68k
Avg Vol (10 day) 3542.31k
Shares Outstanding 5143.79M
Float 142.37M
% Held by Insiders 11.21%
% Held by Institutions 171.01%
Shares Short (Nov 15, 2019) 42.54M
Short Ratio (Nov 15, 2019) 44.68
Short % of Float (Nov 15, 2019) 41.98%
Short % of Shares Outstanding (Nov 15, 2019) 41.76%
Shares Short (prior month Oct 15, 2019) 42.31M

Dividends & Splits

Forward Annual Dividend Rate 41.56
Forward Annual Dividend Yield 41.04%
Trailing Annual Dividend Rate 31.52
Trailing Annual Dividend Yield 31.01%
5 Year Average Dividend Yield 41.65
Payout Ratio 451.72%
Dividend Date 3Dec 12, 2019
Ex-Dividend Date 4Nov 6, 2019
Last Split Factor (new per old) 21/2
Last Split Date 3Aug 31, 2010

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2019
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 15.52%
Operating Margin (ttm)24.56%

Management Effectiveness

Return on Assets (ttm)11.47%
Return on Equity (ttm)20.86%

Income Statement

Revenue (ttm)2.7B
Revenue Per Share (ttm)18.83
Quarterly Revenue Growth (yoy)15.80%
Gross Profit (ttm)1.54B
EBITDA 821.28M
Net Income Avi to Common (ttm)419M
Diluted EPS (ttm)2.90
Quarterly Earnings Growth (yoy)13.60%

Balance Sheet

Total Cash (mrq)172.15M
Total Cash Per Share (mrq)1.2
Total Debt (mrq)1.31B
Total Debt/Equity (mrq)61.66
Current Ratio (mrq)2.11
Book Value Per Share (mrq)14.73

Cash Flow Statement

Operating Cash Flow (ttm)573.29M
Levered Free Cash Flow (ttm)496.76M